Empiri
Houston
About Empiri
Empiri is a biotechnology firm that creates a tool to treat cancer by giving individualized drug response information ahead of treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (May 2022)
- Website: empiricancer.com
- Phone: +1 832 409 4050
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/empiri-40115 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.